# The Phase I/Phase II Clinical Study of VC004 in Patients With Localized Advanced/Metastatic Solid Tumors

> **NCT04614740** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Jiangsu vcare pharmaceutical technology co., LTD** · enrollment: 115 (estimated)

## Conditions studied

- Locally Advanced Solid Tumor
- Metastatic Solid Tumor

## Interventions

- **DRUG:** VC004

## Key facts

- **NCT ID:** NCT04614740
- **Lead sponsor:** Jiangsu vcare pharmaceutical technology co., LTD
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-11-20
- **Primary completion:** 2024-01-31
- **Final completion:** 2024-06-30
- **Target enrollment:** 115 (ESTIMATED)
- **Last updated:** 2022-12-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04614740

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04614740, "The Phase I/Phase II Clinical Study of VC004 in Patients With Localized Advanced/Metastatic Solid Tumors". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04614740. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*